Site search
2898 results for '' found
ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101 [Clofazimine Inhalation Suspension] When Added to Guideline-Based Therap
ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101 [Clofazimine Inhalation Suspension] When Added to Guideline-Based Therap
/
Treatment of functional gut symptoms in patients with quiescent IBD and IBS - a single-blinded parallel trial assessing efficacy of app-delivered gut-directed hypnotherapy versus psycho-education
Treatment of functional gut symptoms in patients with quiescent IBD and IBS - a single-blinded parallel trial assessing efficacy of app-delivered gut-directed hypnotherapy versus psycho-education
/
A first-in-human, phase 1, multi-center, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary evidence of antitumor activity
A first-in-human, phase 1, multi-center, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary evidence of antitumor activity
/
A Phase I/II, randomized, placebo-controlled, multi-arm, dose-finding study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in adults with moderate to severe
A Phase I/II, randomized, placebo-controlled, multi-arm, dose-finding study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in adults with moderate to severe
/
YKP509C003 Protocol: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate [YKP509] as Adjunctive Treatment for Seizures Associated With Lenno
YKP509C003 Protocol: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate [YKP509] as Adjunctive Treatment for Seizures Associated With Lenno
/
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chr
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chr
/
Discovery, design, and analysis of novel allergen peptide therapeutics (Trial Not Registered)
Discovery, design, and analysis of novel allergen peptide therapeutics (Trial Not Registered)
/
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors [Explorer 7]
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors [Explorer 7]
/
Outcomes of redo atrial fibrillation ablation with posterior wall isolation in patients with enduring pulmonary vein isolation (Trial Not Registered)
Outcomes of redo atrial fibrillation ablation with posterior wall isolation in patients with enduring pulmonary vein isolation (Trial Not Registered)
/
Treatment of Stroke Recurrence in CAA with Tranexamic Acid (ACTRN12624001477516)
Treatment of Stroke Recurrence in CAA with Tranexamic Acid (ACTRN12624001477516)
/